The store will not work correctly when cookies are disabled.
N-(2-chlorophenyl)-2-methyl-6-phenylimidazo[1,2-a]pyridine-3-carboxamide
ID: ALA1077738
PubChem CID: 46882743
Max Phase: Preclinical
Molecular Formula: C21H16ClN3O
Molecular Weight: 361.83
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nc2ccc(-c3ccccc3)cn2c1C(=O)Nc1ccccc1Cl
Standard InChI: InChI=1S/C21H16ClN3O/c1-14-20(21(26)24-18-10-6-5-9-17(18)22)25-13-16(11-12-19(25)23-14)15-7-3-2-4-8-15/h2-13H,1H3,(H,24,26)
Standard InChI Key: WHMNCKBUNQISMC-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
-3.5556 -26.6166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5568 -27.4440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8419 -27.8569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8437 -26.2039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1284 -26.6130 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1235 -27.4394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3360 -27.6903 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.8541 -27.0188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3439 -26.3531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3268 -25.5300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6050 -25.1306 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.0337 -25.1046 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.0187 -24.2797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2922 -23.8837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2769 -23.0596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9820 -22.6405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7085 -23.0371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7203 -23.8599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4409 -24.2617 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-4.2681 -26.2045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2669 -25.3784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9807 -24.9661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.6960 -25.3788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.6932 -26.2081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9788 -26.6166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0291 -27.0139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
12 13 1 0
3 6 1 0
13 14 2 0
1 2 1 0
14 15 1 0
5 4 1 0
15 16 2 0
6 7 2 0
16 17 1 0
7 8 1 0
17 18 2 0
18 13 1 0
8 9 2 0
18 19 1 0
9 5 1 0
4 1 2 0
20 21 2 0
9 10 1 0
21 22 1 0
5 6 1 0
22 23 2 0
10 11 2 0
23 24 1 0
24 25 2 0
25 20 1 0
1 20 1 0
10 12 1 0
8 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 361.83 | Molecular Weight (Monoisotopic): 361.0982 | AlogP: 5.22 | #Rotatable Bonds: 3 |
Polar Surface Area: 46.40 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 4.26 | CX LogP: 4.15 | CX LogD: 4.15 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.54 | Np Likeness Score: -1.86 |
References
1. Qiao L, Choi S, Case A, Gainer TG, Seyb K, Glicksman MA, Lo DC, Stein RL, Cuny GD.. (2009) Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors., 19 (21): [PMID:19783434] [10.1016/j.bmcl.2009.09.010] |